Interview: Oliver Technow – President, BioVectra, Canada

Oliver Technow, president at BioVectra, highlights the company’s recent developments; amongst those a significant investment in a manufacturing site near Halifax. The resulting increase in manufacturing capacity by 40 percent will add to BioVectra’s position as the largest biotechnology company on Prince Edward Island, a historic location the CDMO is dedicated to. Oliver, you are just celebrating two years at the head of the company. What have been some of the recent developments for BioVectra?
"The innovative power and capacity in Canada, its tremendous manufacturing potential and the highly skilled workforce needs to be put into a position to successfully grow and keep the value chain intact across all stages of development."
Become a PharmaBoardroom Member for free to access this content
Join the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Already a member? Sign In

Related Interviews

Latest Report